PSMD1 and infection: Intraperitoneal treatment with anti-S1 IgY antibodies resulted in no significant difference in the viral titer in the lung compared with the control adjuvant IgY, but the titer was slightly lower at day 3 post infection in the anti-S1 IgY group compared with the control group (Figure 8A).